Offerings / Regulation CF / Eliaz Therapeutics Inc.
Eliaz Therapeutics Inc.
Regulation Crowdfunding offering on DealMaker Securities · Form C filed June 10, 2026 · Santa Rosa, California
Repeat issuerCommon stockEarly revenueCorporation, Delaware
Business summary pending extraction from the offering statement. The company is a corporation organized in Delaware on September 17, 2015, based in Santa Rosa, CA, with 2 employees and $332,235 of revenue in its most recent fiscal year.
Offering terms
- Security
- Class B Common Stock
- Maximum
- $2,999,995.63
- Price
- $5.56 per unit
- Pricing method
- Not stated
- Deadline
- April 15, 2027
- Oversubscriptions
- Accepted
- Intermediary
- DEALMAKER SECURITIES LLC
Broker-dealer, SEC file 008-70756 - Intermediary fee
- The Issuer will pay DealMaker Securities LLC an 8.5% cash commission fee based on the dollar amount of the Securities sold in the Offering. There is also a one-time $38,000 fee and a $15,000 monthly fee payable to DealMaker Securities LLC or its affiliates
- Intermediary equity
- None.
- Co-issuer
- Eliaz Therapeutics CF Investors SPV, LLC
Financials as filed
| Item | Most recent FY | Prior FY |
|---|---|---|
| Revenue | $332,235 | $302,481 |
| Cost of goods sold | $0 | $0 |
| Net income (loss) | -$1,745,041 | -$954,869 |
| Total assets | $2,589,276 | $738,015 |
| Cash and equivalents | $1,799,510 | $32,814 |
| Accounts receivable | $0 | $0 |
| Short-term debt | $1,796,731 | $2,346,085 |
| Long-term debt | $8,033,117 | $3,888,186 |
| Taxes paid | $0 | $0 |
Two fiscal years as reported on the Form C cover sheet. 2 employees. Offered in 52 states.